ANIK: Anika Therapeutics Forward P/E Multiple

Graphic logo of anikatherapeutics.com (ANIK)

Anika Therapeutics is developing its tissue and joint regeneration segment, ensuring stable supplies to clinics. The company creates safe biomaterials while maintaining strict control over production waste disposal. This price chart shows that the current P/E ratio for Anika Therapeutics (ANIK) shares stands at 12.80. The visualization below allows for a real-time assessment of the market value of this specialized medical device manufacturer.

Anika Therapeutics - ANIK Price to Expected Earnings Ratio (period 07/04/2022 - 11/17/2026)

Anika Therapeutics, Inc. (ANIK) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Fundamental valuation:ANIK Anika Therapeutics
Brand item of anikatherapeutics.com

Patent protection for Anika Therapeutics (ANIK) products enables the company to maintain premium pricing within regenerative medicine. The trend of the company's forward P/E NTM illustrates market expectations regarding this profitability. This ratio correlates the current share price with the projected net income for the following year. Low values signal that the asset is undervalued, while inflated levels increase the risk of a correction. This indicator confirms the resilience of the business model during the execution of financial plans.

Competitors of Anika Therapeutics

Forward P/E Multiple BSX|EW: Price to Expected Earnings Ratio|ResMed Corp - Projected Price to Earnings|Market Cap to Projected Earnings Insulet (PODD)|zimmerbiomet.com - Forward P/E Multiple|Projected Price to Earnings Ratio CooperCompanies|ALGN: Forward P/E Multiple|Projected Price to Earnings Ratio Globus Medical Corp (GMED)|TMDX (TransMedics Group Inc) - Forward P/E Multiple|Price to Future Earnings Ratio ATEC (Alphatec)|Projected Price to Earnings AORT (Artivion)|ENOV (Enovis Corp) - Future Price to Earnings Multiple|Future Price to Earnings Integra LifeSciences Inc. IART|ESTA - Projected Price to Earnings|Beta Bionics, Inc. - Forward P/E Multiple|Projected Price to Earnings Ratio IRADIMED CORPORATION|EMBC: Forward P/E Multiple|Price to Future Earnings Ratio TNDM|AXGN (Axogen Surgical) - Forward P/E Multiple|SI-BONE Corp (SIBN) - Market Cap to Projected Earnings|Forward P/E Multiple OFIX|Forward P/E Multiple bioventus.com (BVS)|Forward P/E Multiple KIDS (OrthoPediatrics Corp)|Forward P/E Multiple Treace Medical Concepts Inc TMCI|SRTA - Future Price to Earnings|CARL: Future Price to Earnings|RXST (RxSight, Inc.) - Projected Price to Earnings|ClearPoint Neuro Inc. - Future Price to Earnings Multiple|STXS (Stereotaxis Corporation) - Forward P/E Multiple|Projected Price to Earnings Ratio Neuronetics Inc. STIM|Future Price to Earnings Sight Sciences Inc. (SGHT)|Orchestra BioMed, Inc. (OBIO) - Forward Price to Earnings Multiple|InspireMD Inc. - Projected Price to Earnings|Forward P/E Multiple Jin Medical International Ltd ZJYL|Vivani Medical Inc - Forward P/E Multiple|Market Cap to Projected Earnings Xtant Medical XTNT|NeuroOne Medical Technologies Corporation (NMTC) - Future Price to Earnings|Price to Expected Earnings Ratio MODD (Modular Med)|MYO (Myomo Inc.) - Forward P/E Multiple|Projected Price to Earnings Envoy Medical, Inc. (COCH)|Forward P/E Multiple VVOS|NVNO - Projected Price to Earnings Ratio|Future Price to Earnings sintx.com SINT|TNON: Price to Future Earnings Ratio|LFWD: Projected Price to Earnings|autonomix.com - Market Cap to Future Earnings Ratio|INVO Bioscience, Inc. (IVF) - Future Price to Earnings|BBLG (Bone Biologics Corp.) - Future Price to Earnings|Projected Price to Earnings AXNX|Biolase Inc. (BIOL) - Market Cap to Projected Earnings|Future Price to Earnings Dynatronics Corp. (DYNT)|Forward P/E Multiple Paragon 28 (FNA)|Future Price to Earnings INVO Bioscience INVO